Interestingly, it has been reported that Hsp90 inhibitor NVP-AUY922 contributed to enhanced radiation sensitivity of lung cancer cells resistant to EGFR-tyrosine kinase inhibitors [33]. Here, HSP90AB1 is linked to lung carcinoma.